What next after shortened TB treatment fails in key trial?
Post Date:
2023-03-13
Source:
Spotlight
Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).
"BPaMZ did exactly what it was supposed to – kill TB. She, however, also expressed concern over the high number of toxicity events."
Read More